Ethics approval and consent to participate
This study was authorized by the French Ethical Research Committee (CPP- “Comité de Protection des Personnes, OUEST IV – NANTES”, CPP 76/21_2) on December 7, 2021. The clinical trial has been registered at ClinicalTrials.gov with the identifier NCT05328024 on April 14, 2022. Participants must provide informed consent in agreement with the Declaration of Helsinki. Subjects will be informed of the objectives of the project and the risks and benefits of the explorations to be carried out. None of the tests will pose risks that could endanger the life of the participants.